Stem cells are biological cell with the unique ability to develop into other cell types in the body and can be used to replace cells and tissues that have been damaged or lost due to disease. They can treat a variety of diseases, including diabetes, liver disease, hepatitis B and C, and others.
Stem cells - cells of the body with properties that a variety of diseases, including diabetes, liver disease, hepatitis B and C, and others can treat.
Treatment with stem cells is called cell therapy.
The activation of the functional systems, normalization of the immune status and metabolic processes are observed after stem cell therapy.
Patients experience an increase in strength, decrease weakness and lethargy, improve appetite, sleep, memory improvement, concentration of attention and sharpness of thinking after a course of cell therapy.
There is a normalization of the emotional background, the mobilization of volitional processes, an increase in the urge to intellectual and creative activity.
The power of nature
Their predecessors are stem cells. They multiply by division, and, unlike the "mature" cells, they have an unlimited number of dividing cycles.
During injury or illness, our cells are damaged or killed. Stem cells in such cases activate and repair damaged tissues or help create new cells. In fact, they are our own microscopic doctors that treat and prevent premature aging. However, the stock of our own stem cells is small.
How it works
The reason one cell can do this is because the main cause of the majority of chronic diseases is either a lack of these cells or a dysfunction of these cells or a combination: these cells just aren’t doing their jobs anymore. This is how our body repairs the organism itself.
What diseases can be cured
Today stem cells are successfully used in the treatment of many complex diseases. For some diseases, other treatments simply do not exist.
Mesenchymal stem cells (MSCs) secrete anti-inflammatory, antifibrotic, immunomodulatory, and regenerative molecules that stimulate the repair and regeneration of inflamed or damaged tissues, and as such are being tested as an option for the treatment of various conditions. In the case of multiple sclerosis, MSC secretions stimulate the body to produce more T-regulatory cells (key for keeping the immune system in check), further modulate the immune system by decreasing the activity of dendritic cells (immune system activators), and exert a direct protective effect on the central nervous system.
Stem cells secrete anti-inflammatory, anti-fibrotic, immunomodulatory and regenerative molecules that stimulate the regeneration of inflamed or damaged tissues. Due to this, in patients there is a decrease in symptoms, and also there is hope for a complete recovery.
Patients have stable and prolonged remission: mental processes improve, motor functions are restored, they experience a surge of optimism and vitality.
Rheumatoid arthritis (RA) is an autoimmune condition in which otherwise healthy cells in the body are mistakenly recognized as a threat and are attacked by the immune system. In the case of RA, the lining of the joints is attacked by the immune system and becomes inflamed, leading to an eventual loss of physical function and disability. Persons affected by RA frequently suffer from other diseases (cardiovascular, pulmonary, and renal for example) and show higher rates of infection.
Mesenchymal stem cells (MSCs) an modulate the immune system and have been used safely to treat certain inflammatory conditions in clinical settings. Additionally, MSCs have the ability to regenerate worn-out cartilage, with umbilical cord-derived MSCs showing greater capacity than other MSC sources.
The main method of treatment is the transformation of stem cells into cartilage cells (chondrocytes), which are injected directly into the affected joint. Also, the method of systemic administration of hematopoietic and / or mesenchymal cells to the bloodstream is used to reduce the manifestations of autoimmune aggression.
Damaged tissues are restored, replenished by stem restoration for regeneration. There is almost complete stopping of disease progression.
Asthma may be triggered by an allergic reaction in the presence of an allergen (allergic asthma), but non-allergic factors may also come into play, for example stress, weather, or a respiratory infection such as a cold or the flu. Chronic asthma may cause an eventual change in the structure of the airway, known as airway remodeling, or the presence of excess scarring (fibrosis).
Stem cells effectively reduce the inflammatory process, restore structural changes, completely eliminate the pulmonary respiratory tract fibrosis, and also normalize their hyperactivity.
In recent studies, stroke patients who were in wheelchairs were able to walk again thanks to stem cell therapy.
OA is a leading cause of disability in patients over age 65 and commonly affects the hands, knees, hips, and spine. Wearing down of cartilage in the joint area may lead to the eventual need for a major replacement surgery with prosthesis. Existing treatments for OA are aimed to reduce pain, but the progression of the condition is not stopped.
OA occurs when inflammatory and oxidative stresses progressively wear down cartilage. Mesenchymal stem cells (MSCs) have been shown to produce factors that are anti-inflammatory and that are key for tissue repair and regeneration. MSCs can also directly become new cartilage tissue. In particular, umbilical cord MSCs have been shown to have a superior potential for cartilage regeneration over other MSC sources.
Treatment with MSCs for OA has been shown also to be effective and safe in clinical settings. Recent clinical trials reported pain relief and improvements in cartilage quality in OA patients treated with bone marrow MSCs, as well as cartilage regeneration with MSCs derived from fat. Another study reported improvements in walking distance and stiffness for 30 months after treatment.
Cellular therapy in joint diseases is aimed at regeneration of cartilage tissue. When the stem cells enter the zone of the affected cartilage tissue, they replace the worn cartilage, contributing to the restoration of its structure.
Mesenchymal stem cells (MSCs) derived from older individuals lose some of their beneficial characteristics. Cellular environment changes with age, and the amount of circulating cytokines and growth factors is altered, which may affect MSC function and growth. Younger MSCs are distinctively spindle-shaped, whereas MSCs from older individuals are larger and flatter. The number of MSCs that may be obtained from bone marrow declines with age, and colonies from older MSG produce a lesser number of viable, newer MSCs. The growth rate of older MSCs as well as the capacity and time to divide are slowed down, and the life span to proliferate is shorter than in MSCs derived from younger individuals.
When injected into the body of a patient, stem cells migrate to the affected organs and provide a powerful upgrade of entire biological structures, normalize metabolic processes, bring the immune status of the body into conformity, and activate anti-tumor factors.